Awareness and Self-Reported Knowledge and Training on Nutrition in Older People among Primary Care Practitioners.

OBJECTIVES: To assess the awareness and training of primary care physicians on nutrition in older patients. DESIGN: Observational, real-world data survey. SETTING: Primary Care. PARTICIPANTS: One hundred sixty-two physicians, generalists and specialists, working in primary care. MEASUREMENTS: Participants received an online questionnaire with 18 questions concerning the importance of nutrition, degree of knowledge, needs, and training in nutrition. The results were evaluated using univariate descriptive analysis, with a percentage for each chosen answer. Logistic regression models were used to evaluate if answers were related to training in nutrition and professional experience. RESULTS: 43.2% of participants reported that nutrition is very important in individuals over 65 years old, and 90% were aware of the importance of nutrition in healthy aging. Nutritional problems affect 30 to 50% of patients, according to 44.7% of participants. 89.2% agree about the need for nutritional assessment in older patients; however, the professionals believe they should be better prepared. Two out of three respondents consider the training received in nutrition during their undergraduate course or continuing medical education as deficient. Time of professional practice was mainly associated with conceptual facts, while continuing medical education did with practical issues, mainly the use of screening and diagnostic tools [FRAIL (OR: 3.16; 95%IC: 1.55-6.46), MNA-SF (OR: 6.455; 95%IC: 2.980-13.981) and SARC-F (OR: 3.063; 95%IC: 1.284-7.309)]. CONCLUSION: Although primary care professionals are aware of the importance of nutrition in older patients, there are still gaps in daily practice that could be improved by developing educational strategies.

[Pharmacological treatment of obesity for Primary Care physicians]. / Tratamiento farmacológico de la obesidad para médicos de Atención Primaria.

Obesity is a disease of high prevalence in Primary Care clinics. It is associated with major comorbidities (dyslipidaemia, diabetes, hypertension) that increase morbidity and mortality, health expenditure, and reduces the quality of life of patients. Changes in lifestyle are still the pillars of the treatment of excess weight. Pharmacological treatment should be considered when there are difficulties in achieving weight loss goals. In this article, a review is presented on the currently authorised drugs for the treatment of obesity and overweight with major comorbidities.

Estudios españoles de crecimiento: situación actual, utilidad y recomendaciones de uso / Growth spanish studies: the current situation, their effectiveness and recommendations for their use

La monitorización del crecimiento infantil tiene, además de su utilidad clínica para el seguimiento de la salud infantil, una utilidad social, como indicador de los avances de equidad en el mundo. En España ha habido una larga tradición en la realización de estudios de crecimiento. Recientemente, 5 grupos que han efectuado estudios de crecimiento en la última década en las poblaciones de Andalucía, Barcelona, Bilbao, Madrid y Zaragoza han fusionado sus datos, lo que ha dado lugar a los estudios transversales españoles 2008 y 2010, y al estudio longitudinal español 1978/2000. Estos estudios han demostrado que las diferencias regionales de crecimiento en España han desaparecido y que han tenido lugar cambios seculares en las últimas décadas, de modo que la talla adulta se ha acercado a la de otros países europeos y americanos, manteniéndose por debajo de algunos países del centro y norte de Europa. Se han observado también diferencias entre los estudios españoles y el estudio multicéntrico de la Organización Mundial de la Salud (OMS), debido, entre otras razones, a los diferentes criterios para la selección de la muestra, «poblacional» en los estudios españoles, y «socioeconómico» y «nutricional» en el estudio de la OMS. En el momento actual, para la población española, es adecuado utilizar como estándares de referencia los estudios españoles integrados, tanto el transversal como el longitudinal. Dada la existencia de tendencias seculares, sería deseable continuar realizando en el futuro estudios transversales prospectivos, homogéneos metodológicamente, representativos de las distintas regiones, con una periodicidad de 10-15 años (AU)

The child growth assessment is useful not only for the follow up of children health but also for social purposes, as an indicator of the equity advances in the world. In Spain there has been a long tradition in carrying out growth studies. During the last decade five Spanish research groups have conducted studies among the population of Andalucía, Barcelona, Bilbao, Madrid and Zaragoza. They have combined their data and have produced the «Transversal Spanish Studies 2008 and 2010» and the «Longitudinal Spanish Study 1978/2000». These studies have showed that in Spain the regional differences on growth have disappeared, and that this has had a secular trend in the last decades. The Spanish adult height has approached to other European and American countries, still below some Centre and North European countries. There are some differences between the Spanish growth studies and the multicentric World Health Organization (WHO) growth study. This is due, among other reasons, to the different criteria that are used for the sample selection. In Spain the studies are based on the «population» criteria, whereas the WHO study is based on the «socioeconomic» and «nutritional» criteria. Currently for the Spanish population is appropriate to use, as standard reference, the Spanish multicentric studies, which are the transversal as well as the longitudinal studies. Due to the recent secular trend, it would be convenient to carry out, in the future, prospective transversal growth studies, methodologically homogeneous, representatives of the different Spanish regions, and preferably made every ten to fifteen years (AU)

[Spanish growth studies: the current situation, their effectiveness and recommendations for their use]. / Estudios españoles de crecimiento: situación actual, utilidad y recomendaciones de uso.

The child growth assessment is useful not only for the follow up of children's health but also for social purposes, as an indicator of the equity advances in the world. In Spain there has been a long tradition in carrying out growth studies. During the last decade five Spanish research groups have conducted studies among the population of Andalucía, Barcelona, Bilbao, Madrid and Zaragoza. They have combined their data and have produced the "Transversal Spanish Studies 2008 and 2010" and the "Longitudinal Spanish Study 1978/2000". These studies have showed that in Spain the regional differences on growth have disappeared, and that this has had a secular trend in the last decades. The Spanish adult height has approached to other European and American countries, still below some Centre and North European countries. There are some differences between the Spanish growth studies and the multicentric World Health Organization (WHO) growth study. This is due, among other reasons, to the different criteria that are used for the sample selection. In Spain the studies are based on the "population" criteria, whereas the WHO study is based on the "socioeconomic" and "nutritional" criteria. Currently for the Spanish population is appropriate to use, as standard reference, the Spanish multicentric studies, which are the transversal as well as the longitudinal studies. Due to the recent secular trend, it would be convenient to carry out, in the future, prospective transversal growth studies, methodologically homogeneous, representatives of the different Spanish regions, and preferably made every ten to fifteen years.

Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children.

BACKGROUND: Treatment with GH promotes linear growth and decreases body fat in patients with isolated GH deficiency (GHD). However, few studies have analyzed how GH replacement modifies ghrelin levels and the adipokine profile and the relationship of these modifications with the metabolic changes. AIMS: To analyze the eventual differences between serum levels of leptin, leptin soluble receptor (sOBR), resistin, adiponectin, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), total (TG) and acylated ghrelin (AG) and lipid and glycemic profiles in children with GHD, as well as to determine the effect of GH replacement on these parameters during the first year of therapy. SUBJECTS AND METHODS: Thirty pre-pubertal (Tanner stage I) GHD children and 30 matched controls were enrolled. Children with GHD were studied before and after 6 and 12 months of GH treatment. Weight, height, BMI, fasting glucose, insulin, lipid profile and serum levels of adipokines and ghrelin were studied at every visit. Adi - pokines, insulin and ghrelin levels were determined by using commercial radio- and enzymoimmunoassays. RESULTS: At baseline children with GHD had significantly higher sOBR (p<0.01) and adiponectin (p<0.01) levels than controls. Treatment with GH resulted in a decline in leptin (p<0.05) and TG (p<0.001) levels, an increase of homeostasis model assessment index and restored IGF-I levels (p<0.001). CONCLUSIONS: These data indicate that GH replacement has a negative effect on leptin levels and may also produce a slight unfavorable effect on carbohydrate metabolism. In addition, the changes observed in the adipokine profile appear to be independent of body mass index.

Effects on the glutathione pool of the insulin-induced hypoglycaemia test.

The growth hormone (GH) stimulation test shows that hypoglycaemia can cause the generation of free radicals, or reactive oxygen species (ROS), together with the migration of amino acids, glutathione and various ions to the interior of fat or muscle cells. The aim of the present study is to evaluate the splitting of plasma glutathione into its two fractions, oxidized (GSSG) and reduced (GSH), after the induction of hypoglycaemia with insulin in the course of the GH stimulation test. We studied 41 short children (47% boys and 53% girls) at the Paediatric Department of the San Cecilio Hospital (Granada, Spain) to evaluate their size and growth. A GH stimulation test using insulin-induced hypoglycaemia was carried out, and GSSG and GSH values in plasma were determined. The glutathione level is associated with the level of glucose reached at 30 min after initiating the test. This provoked an initial reduction in the GSH/GSSG ratio, which fell to a minimum at 30 min after starting the test, although the values rose again at 60 min. The results obtained show that the insulin-induced GH stimulation test produces a decrease in plasma levels of the glutathione pool, that persists at least for 2 hours following the beginning of the test.

[Spanish cross-sectional growth study 2008. Part II. Height, weight and body mass index values from birth to adulthood]. / Estudio transversal español de crecimiento 2008. Parte II: valores de talla, peso e índice de masa corporal desde el nacimiento a la talla adulta.

INTRODUCTION: In developed countries a secular trend in growth has been reported. Our aim was to evaluate weight, height and body mass index (BMI) values in a Spanish population coming from Andalusia, Barcelona, Bilbao and Zaragoza, and to compare these values with those obtained before 1988 (BIB 88 and CAT 87 studies). SUBJECTS AND METHODS: Cross-sectional evaluation of height, weight and BMI in 32,064 subjects (16,607 males and 15,457 females) from birth to adulthood between the years 2000 and 2004. Three subpopulations were evaluated: a) 5,796 (2,974 males, 2,822 females) newborns at term from normal gestations; b) 23,701 (12,358 males; 11,343 females) children and adolescents 0.25-18 years old, and c) 2,567 (1,275 males, 1,292 females) young adults 18.1-24 years of age. All were healthy caucasians, and their parents from Spanish origin. The LSM method was used. RESULTS: Mean, standard deviation, Skewness index and percentiles values with a 0.25-0.5 year-period intervals from birth to adulthood are reported. As regards the data obtained previously in Spanish populations, an increase of 1.8 cm, 1.4 cm and 3.3 cm were observed in adult height for percentiles 3, 50 and 97 in males respect to BIB 88 and 2.5 cm, 3.3 cm and 3.8 respect to CAT 87. In females these values were 3.5 cm, 2.5 cm and 4.2 cm respect to BIB 88 and 3.5 cm, 3.1 cm and 3.9 cm respect to CAT 87. The corresponding values for weight, in males, were increased in 5.4 kg, 6.2 kg and 11.7 kg respect to BIB 88 and 6.7 kg, 6.3 kg and 10.1 kg respect to CAT 87; in females these increased were 1.7 kg, 2,2 kg and 8.3 kg respect to BIB 88 and 1.8 kg, 2.4 kg and 3.6 kg respect to CAT 87. The corresponding increased for BMI values, in males, were 2.0, 1.4 and 3.9 respect to BIB 88 and 0.1, 0.2 and 5.3 respect to CAT 87; in females these values were 0.9, 0.4 and 3.7 respect to BIB 88 and 1.8, 0.1 and 4 respect to CAT 87. In young adults, 25 and 30 BMI values correspond to percentiles 80 and 97 in males, and 85 and 97 in females. Mean values of adult height were similar to those observed in other longitudinal and cross-sectional Spanish, European, and American studies, but lower than those reported for German, Swedish and Netherlands populations. CONCLUSIONS: A secular trend of growth was observed in our population with a non-proportional increased of weight to height ratio (BMI) values, particularly for those corresponding to the 97 percentile. The need of periodical updates of growth data used in the evaluation of children and adolescents is required.

Effects of metabolic control on vitamin E nutritional status in children with type 1 diabetes mellitus.

OBJECTIVE: To evaluate the effects of the metabolic control of the insulin-dependent diabetes mellitus (IDDM) on the nutritional status of vitamin E. METHODS: A total of 47 children with IDDM and a mean age of 11.91+/-1.60 (mean+/-SD) years were studied, matched for age and sex with 16 healthy children (11.75+/-1.83 years). Following the American and British Associations for IDDM, we used a classification of "good", "moderate" or "poor" control of the illness: (a) good control [glycosilated haemoglobin (HbAlc) < or =7%]; (b) moderate control (7%< HbAlc < or =8%); and (c) poor control (HbAlc>8%). Serum concentrations of total cholesterol (CHOL), triglycerides (TG), high-density lipoproteins-cholesterol (HDLc), very low- and low-density lipoproteins cholesterol (VLDLc and LDLc), plasma and erythrocyte vitamin E (Vit Ep and Vit Ee) and plasma vitamin A (Vit Ap) were measured in all children. RESULTS: The children with "poor" metabolic control of the illness presented significantly higher plasma concentrations of CHOL, LDLc, VLDLc, LDLc/HDLc, (VLDL+LDL)c/HDLc, TG and Vit Ep; higher indices Vit Ep/Vit Ee and Vit Ep/Vit Ap relative to those with a "good" control of the illness. Direct-linear correlations were found between Vit Ep and the percentage of HbAlc and with the markers of atherogenic risk in the IDDM children. CONCLUSION: There is a significant rise in Vit Ep concentrations as metabolic control of the illness worsens, whereas Vit Ee remained unchanged. These results suggest that vitamin E maintains its nutritional status despite a poor control of the IDDM during childhood.

Pubertad y melatonina / Puberty and melatonin

Antecedentes: La melatonina, principal producto hormonal de la glándula pineal tiene una producción nocturna máxima. Aun cuando no todos los investigadores están de acuerdo, numerosos datos sugieren que los niveles elevados prepuberales mantienen el eje hipotálamo-hipófiso-gonadal en reposo, ejerciéndose de este modo un efecto inhibidor del desarrollo puberal. Como consecuencia, el descenso de los valores séricos de melatonina con la edad activa la secreción pulsátil de hormona liberadora de gonadotropina (GnRH) y de esta forma el eje reproductor, y en consecuencia se produce el comienzo de la pubertad. Objetivo. Estudiar el patrón de excreción urinaria de melatonina en niños de distintas edades, las características de su eliminación rítmica y analizar si la pubertad se asocia a una disminución significativa de su producción. Material y métodos: Se estudiaron 32 niños (17 varones y 15 mujeres), realizándose determinaciones urinarias (mediante radioinmunoanálisis [RIA]) de melatonina en orina diurna (recogida entre las 9:00 y 21:00 h) y nocturna (recogida entre las 21:00 y 9:00 h del día siguiente) y determinaciones sanguíneas de hormona luteinizante (LH), foliculoestimulante (FSH), testosterona, estradiol y sulfato de deshidroepiandrosterona (DHEAS). Se estudia el patrón circadiano y la secreción de melatonina en los distintos estadios de Tanner de desarrollo puberal (análisis de varianza [ANOVA]). Resultados: No hay diferencias significativas entre la secreción diurna y nocturna de melatonina entre varones (1,38 0,52 pg/ ml melatonina diurna y 6,92 2,06 pg/ml melatonina nocturna) y mujeres (1,15 0,43 pg/ml melatonina diurna y 11,41 4,32 pg/ml melatonina nocturna). Hay diferencias altamente significativas (p < 0,001) entre las tasas diurnas y nocturnas de secreción de melatonina en ambos sexos. Hay diferencias altamente significativas (p < 0,001) en la secreción diurna, nocturna y total entre los distintos estadios de Tanner de desarrollo puberal, encontrándose en las comparaciones entre grupos que entre los estadios I y II, tanto en varones como en mujeres se observa un significativo descenso de estas tasas de secreción. Hay una significativa disminución de la secreción de melatonina con la edad en ambos sexos (relación lineal), con mayor descenso nocturno. No hay relación entre la secreción de melatonina y la de estradiol, testosterona, LH, FSH y DHEAS. Conclusiones: La secreción de melatonina sigue un patrón circadiano, con mayor secreción nocturna, siendo la amplitud de este ritmo significativamente superior en niñas, por mayor secreción nocturna. Se observa un descenso significativo de la secreción entre los estadios I y II de desarrollo puberal, con descenso mantenido posterior en los siguientes estadios. (AU)

[Puberty and melatonin]. / Pubertad y melatonina.

BACKGROUND: Melatonin is the main hormone secreted by the pineal gland and secretion is maximal at night. Although researchers disagree, numerous data suggest that elevated melatonin levels during the prepubertal age maintain the hypothalamic-pituitary-gonadal axis in quiescence, thus exerting an inhibitory effect on pubertal development. The decrease in serum melatonin with advancing age activates hypothalamic pulsatile secretion of gonadotropin-releasing hormone and consequently the reproductive axis, which results in the onset of puberty. OBJECTIVE: To evaluate urinary melatonin levels in children of different ages and the characteristics of its rhythmic excretion and to determine whether puberty is associated with a significant reduction in urinary melatonin levels. MATERIAL AND METHODS: Thirty-two children were studied (17 boys and 15 girls). Concentrations of 24-h urinary melatonin were quantified by radioimmunoassay in daytime samples (collected between 9.00 and 21.00) and nighttime samples (collected between 21.00 and 9.00 on the following day). Blood levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, testosterone and dehydroepiandrosterone sulfate (DHEAS) were calculated. Circadian rhythms and melatonin secretion in the various Tanner stages were assessed (ANOVA). RESULTS: No significant differences were found between day- and nighttime secretion of melatonin among boys (daytime melatonin: 1.38 0.52 pg/ml; nighttime melatonin: 6.92 2.06 pg/ml) and girls (daytime melatonin: 1.15 0.43 pg/ml; nighttime melatonin: 11.41 4.32 pg/ml). Highly significant differences were found (p < 0.001) between the day and night rates of melatonin secretion in both genders. Highly significant differences (p < 0.001) were also found in day-, nighttime and total secretion among the different Tanner stages. Comparison among groups revealed a significant decrease in secretion rates in stages I and II in both boys and girls. Melatonin significantly decreased with age in both sexes (lineal relationship). This decrease was greater at night. No relationship was found between the secretion of melatonin and estradiol, testosterone, LH, FSH and DHEAS. CONCLUSIONS: Melatonin secretion follows a circadian pattern, with greater secretion at night. The change in this rhythm was significantly greater in girls, due to greater nighttime secretion. Secretion significantly decreases in Tanner stages I and II with subsequent decreases in the later stages.

Effect of propranolol plus exercise on melatonin and growth hormone levels in children with growth delay.

The pineal gland in humans is under both alpha- and beta-adrenergic control, although it seems that beta1-adrenoceptors are mainly implicated in melatonin secretion. In the present study, we evaluated the role of beta-adrenergic innervation on melatonin production and its relation with the production of growth hormone (GH). Thirty-four children (15 males and 19 females, mean age 10.5 +/- 0.8 years) from the University of Granada Hospital were studied. The children were included in a protocol for the evaluation of growth delay using the propranolol + exercise test. This standardized test allowed us to study simultaneously the role of an unspecific beta-adrenergic blocker such as propranolol and of an adrenergic stimulus such as exercise on the pineal production of melatonin. Changes in plasma levels of melatonin and GH were determined at basal, 120 and 140 min after the test was applied. Hormonal determinations were carried out by commercial radioimmunoassay kits previously standardized in our laboratory. The results show a significant decrease in plasma melatonin levels at 120 and 140 min after the test (P < 0.05), whereas GH levels increased significantly at 140 min (P < 0.001). The decrease of melatonin levels was a consequence of the test, since in a control group, the circadian decay of melatonin was significantly less pronounced (P < 0.05). These data suggest an inverse relationship between melatonin and GH after the propranolol + exercise test, and the reduction in melatonin may be related to its depletion by exercise-induced oxidative stress.

Characterization of nocturnal ultradian rhythms of melatonin in children with growth hormone-dependent and independent growth delay.

To assess the existence of a possible nocturnal ultradian rhythm of melatonin in children, we analyzed 28 pediatric patients (mean age, 9.08 +/- 2.2 yr) with GH-dependent and GH-independent growth delay. Plasma melatonin was measured by RIA in children sampled every 30 min between 2100-0900 h. Statistical analysis consisted of cluster analysis to examine the presence of peaks and troughs. The pattern of melatonin levels was related to the cause of growth delay, although the means of the nocturnal concentrations of melatonin were similar in all children. Interestingly, children with a GH deficit showed a nearly normal melatonin profile, whereas children with normal GH values but abnormal growth displayed atypical profiles of melatonin. The results also prove the existence of an ultradian rhythm of melatonin in most of the patients studied. The ultradian rhythm of melatonin in children was characterized by irregular interburst intervals, thus differing from the rhythm previously described in adults that had an almost constant pulse frequency. Moreover, the existence of low and high melatonin producers was revealed in the study, a feature unrelated to the cause of growth delay. The group of children with a GH deficit showed the lowest values of integrated melatonin production and of the area of peaks and troughs. These results prove that children exhibit an ultradian rhythm of melatonin like that in adults. Whereas it is not clear whether the episodic production of melatonin is required for its biological actions, the existence of irregular pulses may reflect endocrine influences at this age and/or the immaturity of the intrinsic pulse generator.

Institutional childcare and the affective deficiency syndrome: consequences on growth, nutrition and development.

It is generally accepted that, in the face of certain family and social circumstances, a minor may need to be taken into care within an institution, a course of action that provides, at least, an alternative to the risks of abandonment and life "on the street". Nevertheless, the reality of life in childcare centres can lead to children undergoing an additional trauma after escaping the miserable situation of the family home. After the advances made in recent years (economic, healthcare, social, legal, etc.), it has been suggested that the institutionalization of a minor, as a rule, does not in itself represent a negative factor for the child's wellbeing. In order to test this hypothesis, we studied two groups of children in care. The first group comprised 101 children being cared for in a large traditional institution during 1986. The second group was composed of 66 children studied in 1996, resident in a smaller, charitable institution, providing a more family-like atmosphere. Growth evaluation methods were applied, including anthropometry (weight, height, weight/height ratio, body mass index, Rorer index and weight index), nutrition (skin folds, body density, percentage of body fat and weight of the fat) and development (psychometry: Boehm test, CMMS, Raven and EIT). The data were analyzed by means of the Student's t-test. The most important result obtained was the demonstration that the second group of children presented results that were clearly higher in nearly all the studied variables, thus showing that institutionalization in itself does not have a negative influence on child development.

Effect of clonidine on plasma ACTH, cortisol and melatonin in children.

An interaction between melatonin and adrenocorticotropin (ACTH) seems to occur in humans and both hormones respond to beta-adrenergic stimulation. As in lower animal species, human pineal gland also contains alpha2-adrenergic receptors as does the hypothalamus-pituitary axis. In this study the response of the pineal gland and of the hypothalamus-pituitary-adrenal axis to alpha2-adrenergic stimulation was assessed. Twenty-nine children (21 males, mean age 11.2 +/- 0.6 yr and eight females, mean age 9.1 +/- 1.1 yr) from the University of Granada Hospital were studied. The children were diagnosed as having growth problems but with a normal response of growth hormone (GH) to clonidine test. Changes in plasma levels of ACTH, cortisol and melatonin were evaluated in these children after oral administration of the alpha2-adrenoceptor agonist clonidine (100 microg/m2) or a placebo. Plasma ACTH, cortisol and melatonin were measured before (basal) and at 30, 60 and 90 min after oral clonidine or placebo administration. Hormonal determinations were carried out by commercial radioimmunoassay kits, previously standardised in our laboratory. The results show a significant decrease in plasma ACTH, cortisol and melatonin 30 min after clonidine administration (P < 0.001), reaching lowest values at 90 min after the drug was administered. The reduction in the levels of these hormones is independent of their normal circadian decay since the control group showed a significantly different pattern of behaviour. These data support the existence of an inhibitory alpha2-adrenergic influence on both the pineal gland and the hypothalamus-pituitary-adrenal in children and further support the presence of alpha2-adrenoceptors in the human pineal gland.

The relationship between bone age, chronological age and dental age in children with isolated growth hormone deficiency.

AIM: To relate dental age and bone age to chronological age in a group of children with isolated growth hormone deficiency (GHD). DESIGN: A group of 25 children between the ages of 6 and 18 years, diagnosed as having GHD were studied. Of these, 16 were male and nine were female, undergoing replacement therapy with growth hormone (GH) over 2.5 years. Dental age (DA) was estimated from orthopantograms (Haavicko Methods) and compared to bone age (BA) by Greulich and Pyle Standards, and chronological age (CA). RESULTS: CA versus BA--there was a statistically significant difference of 1.52 years between the average chronological age and bone age (t = 5.61, P < 0.001). CA versus DA--there was a statistically significant difference of 0.92 years between the average chronological age and dental age (t = 3.93, P < 0.001). BA versus DA--statistically nonsignificant differences were found between the average bone age and dental age (t = -0.60, P = 0.10). CONCLUSION: After 2.5 years of therapy with growth hormone both DA and BA showed a significant delay compared to CA. Despite the fact that some catch-up occurs in speed of growth there is no evidence from the children in our study that might support the occurrence of a similar speed-up in dental age.

Segmental neurofibromatosis with contralateral lentiginosis.

A female patient with neurofibromatosis (involving the segmental arrangement of neurofibromata) and contralateral partial lentiginosis is described. This case is an unusual presentation of segmental neurofibromatosis.